These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Causes of late renal transplant dysfunction]. Szabó A, Müller V. Orv Hetil; 2002 Dec 22; 143(51):2811-9. PubMed ID: 12638307 [Abstract] [Full Text] [Related]
4. The natural history of chronic allograft nephropathy. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR. N Engl J Med; 2003 Dec 11; 349(24):2326-33. PubMed ID: 14668458 [Abstract] [Full Text] [Related]
8. Transplanting kidneys from CMV-seropositive donors to CMV-seronegative recipients is not associated with poorer renal allograft function or survival. McLaughlin K, Sandhu S, Wu C, Muirhead N, Hollomby D, Jevnikar A. Nephrol Dial Transplant; 2005 Jan 11; 20(1):176-80. PubMed ID: 15572381 [Abstract] [Full Text] [Related]
9. Clinical correlates to chronic renal allograft rejection. Kasiske BL. Kidney Int Suppl; 1997 Dec 11; 63():S71-4. PubMed ID: 9407426 [Abstract] [Full Text] [Related]
10. Protocol biopsies after kidney transplantation. Böhmig GA, Regele H, Hörl WH. Transpl Int; 2005 Feb 11; 18(2):131-9. PubMed ID: 15691264 [Abstract] [Full Text] [Related]
11. [Non-immunological risk factors associated with chronic allograft nephropathy following kidney transplantation]. Shiroki R, Hoshinaga K. Hinyokika Kiyo; 2002 Nov 11; 48(11):693-7. PubMed ID: 12512144 [Abstract] [Full Text] [Related]
12. [Pathogenesis of chronic renal allograft dysfunction]. Morozumi K, Takeda A, Uchida K. Hinyokika Kiyo; 2002 Nov 11; 48(11):673-7. PubMed ID: 12512140 [Abstract] [Full Text] [Related]
13. [Role of transforming growth factor beta-1 gene polymorphisms in the development of chronic allograft nephropathy in renal transplant recipients]. Iñigo P, Lario S, Campistol JM, Bescós M, Campos B, Oppenheimer F. Nefrologia; 2003 Nov 11; 23(4):312-20. PubMed ID: 14558330 [Abstract] [Full Text] [Related]